You are assisting a scientist in early-stage drug discovery. Answer their message as you would for a colleague.

For reference, this is the output of our in-house toxicity predictor (ToxPred) for the compound in the question, as JSON:
```json
{
  "applicability": {
    "chemical_guard": {
      "method": "element_rules_v1",
      "reasons": [
        "contains uncommon element(s): B"
      ],
      "status": "limited"
    },
    "method": "element_rules_v1",
    "reasons": [
      "contains uncommon element(s): B"
    ],
    "similarity_domain": null,
    "status": "limited"
  },
  "canonical_smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O",
  "predictions": {
    "herg": {
      "label": "non_blocker",
      "measurement": "hERG channel blockade liability",
      "model_id": "herg-tox21-chemberta-v1",
      "probability_blocker": 0.21694640815258026,
      "threshold": 0.4133453071117401,
      "threshold_source": "artifact"
    },
    "tox21": {
      "assays": {
        "NR-AR": {
          "active": false,
          "probability_activity": 0.29062190651893616,
          "threshold": 0.9399998188018799,
          "threshold_source": "artifact"
        },
        "NR-AR-LBD": {
          "active": false,
          "probability_activity": 0.1814471334218979,
          "threshold": 0.489999920129776,
          "threshold_source": "artifact"
        },
        "NR-AhR": {
          "active": false,
          "probability_activity": 0.15595905482769012,
          "threshold": 0.6799998879432678,
          "threshold_source": "artifact"
        },
        "NR-Aromatase": {
          "active": false,
          "probability_activity": 0.22869011759757996,
          "threshold": 0.7099998593330383,
          "threshold_source": "artifact"
        },
        "NR-ER": {
          "active": false,
          "probability_activity": 0.43206915259361267,
          "threshold": 0.5099999308586121,
          "threshold_source": "artifact"
        },
        "NR-ER-LBD": {
          "active": false,
          "probability_activity": 0.2816884517669678,
          "threshold": 0.6799998879432678,
          "threshold_source": "artifact"
        },
        "NR-PPAR-gamma": {
          "active": false,
          "probability_activity": 0.11700492352247238,
          "threshold": 0.4199999272823334,
          "threshold_source": "artifact"
        },
        "SR-ARE": {
          "active": false,
          "probability_activity": 0.27510717511177063,
          "threshold": 0.49999991059303284,
          "threshold_source": "artifact"
        },
        "SR-ATAD5": {
          "active": false,
          "probability_activity": 0.0835905373096466,
          "threshold": 0.47999992966651917,
          "threshold_source": "artifact"
        },
        "SR-HSE": {
          "active": false,
          "probability_activity": 0.23680557310581207,
          "threshold": 0.5099999308586121,
          "threshold_source": "artifact"
        },
        "SR-MMP": {
          "active": false,
          "probability_activity": 0.18207761645317078,
          "threshold": 0.5399999022483826,
          "threshold_source": "artifact"
        },
        "SR-p53": {
          "active": false,
          "probability_activity": 0.18288762867450714,
          "threshold": 0.34999996423721313,
          "threshold_source": "artifact"
        }
      },
      "measurement": "Twelve independent Tox21 assay activities",
      "model_id": "herg-tox21-chemberta-v1",
      "task_order_version": "tox21-12task-v1"
    }
  },
  "requested_endpoints": [
    "herg",
    "tox21"
  ],
  "unavailable_endpoints": []
}
```

Can we rely on the model's hERG and Tox21 predictions for bortezomib (B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O)?